XSOLLA
19.8.2024 04:01:29 CEST | Business Wire | Press release
Xsolla, a global video game commerce company, will present a series of sessions at the Devcom Developer Conference 2024 and attend Gamescom 2024, the world’s largest computer and video games event, from August 19th to August 23rd in Cologne, Germany. Xsolla is hosting six informative speaking sessions at Devcom, including two on Best Practices for Web Shop development and a Partner Spotlight.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240818573649/en/
(Graphic: Xsolla)
“This is a pivotal year in mobile game development and for building games in Europe and globally,” described Xsolla’s Chief Marketing and Growth Officer, Berkley Egenes. “These sessions will cover various topics, including engagement best practices, rules of success for creating a web shop, the gaming industry's future, approaches to community engagement, the state of the backend technology, and how to avoid five significant pitfalls.”
Xsolla will exhibit at Gamescom from Hall 2.2, Booth #A-030-B-037. Attendees can meet with Xsolla experts and participate in demonstrations of the latest solutions and offerings designed to provide opportunities for cross-play and payment for players and developers in 2024.
“It’s an incredible opportunity to connect with the vibrant game development community, share our insights, and host speaking sessions that we hope will inspire and inform,” said Egenes. “Being a part of these events is always an exciting experience, and we can’t wait to engage with fellow developers and industry professionals.”
Xsolla Speaker Sessions Schedule:
When: Monday, August 19th, 2024, 1:00 PM - 1:30 PM
Location: Xsolla Stage #5, 1st floor, Confex Center, Devcom
Topic: Engagement best practices from leading EMEA mobile game developers
Learn how Xsolla’s solutions, designed for mobile game developers, can instantly boost revenue and player engagement beyond app stores. In this session, Josephine Friday, Sales Director, US, and Berkley Egenes, Chief Marketing and Growth Officer at Xsolla, along with Joan Lluis, Producer at Tilting Point, will share techniques and explore strategies to elevate your mobile monetization efforts. Since 2020, Xsolla has led global mobile game monetization by developing solutions, including Web Shop, SDK, Instant Web Shop, and industry-first best practices guides. Don’t miss this chance to learn from the industry's experts.
When: Monday, August 19th, 2024, 1:30 PM - 2:00 PM
Location: Xsolla Stage #5, 1st floor, Confex Center, Devcom
Topic: Leveling up: The future of gaming
Join industry experts Nick Grant, Interim CEO of 80 Level, Kasper Weber, Founder & CEO of Beyond Creative, Alexander Fernandez, CEO of Streamline Media Group, and Bridget Stacy, VP of Marketing at Xsolla, for a visionary discussion on the future of the gaming industry over the next 5 years. This talk leverages proprietary and public data, insights from partners, and Xsolla’s extensive network of gaming professionals. We will delve into anticipated advancements, innovative trends, and transformative shifts. Key topics include performance projections, comparisons to other emerging industries, and detailed forecasts on how gaming will evolve and impact the global market. Don't miss this opportunity to gain valuable insights and prepare for the dynamic changes ahead in the gaming world.
When: Monday, August 19th, 2024, 2:00 PM - 2:30 PM
Location: Xsolla Stage #5, 1st floor, Confex Center, Devcom
Topic: How to fail your studio in 5 easy steps
This session, led by Manny Hachey, Accelerator Program Director at Xsolla, is aimed at new founders and teams looking to create their first startup. Relevant to any product, platform, or target audience, this talk will help you avoid five major business pitfalls. Manny Hachey shares hard-earned, painful lessons with you now to help ensure you don't make the same mistakes in the future.
When: Tuesday, August 20th, 2024, 11:30 AM - 12:00 PM
Location: Xsolla Stage #5, 1st floor, Confex Center, Devcom
Topic: Community first: publisher and indie approaches to community engagement
The biggest challenge developers face today is discoverability. Developers can no longer rely solely on publishers for community-building efforts. In this fireside chat, Andrei Podoprigora, Co-Founder & CEO of Forklift Interactive, Nathan Sölbrandt, Business Development Director - EMEA at Xsolla, and Jan Halwe, Business Development Manager at ByteRockers' Games, will explore various aspects of community building in 2024 — from iterative feedback during development to ongoing post-launch engagement. This presentation includes diverse perspectives on effectively growing and connecting with a community in the modern digital landscape.
When: Tuesday, August 20th, 2024, 12:00 PM - 12:30 PM
Location: Xsolla Stage #5, 1st floor, Confex Center, Devcom
Topic: 5 rules of success for creating a web shop for your mobile game
Web monetization for mobile games via web shops remains a top-of-mind conversation in the video games industry. With nearly 400 web shops completed, Artem Liubutov, Xsolla's Director of Products (Monetization), unveils 5 rules of success to help you get the most out of your web shop. He will present the best ways to convey additional value, reduce friction, set up LiveOps, and lead your web shop to success.
When: Tuesday, August 20th, 2024, 12:30 PM - 1:00 PM
Location: Xsolla Stage #5, 1st floor, Confex Center, Devcom
Topic: Gaming backend: To build or to buy
As consumer appetite for online and multiplayer gaming continues to rise, developers across the industry are questioning whether to build or buy a gaming backend for their next project. Join Matthew Morris, Chief Commercial Officer at Code Wizards, as he leads a panel of experts, including Jean-Philippe Steinmetz, Head of Xsolla Backend, Alexander Bergendahl, CEO of LootLocker, and Tim Morten, Founder & CEO of Frost Giant Studios, to explore the state of backend technology and address this crucial question.
Attendees can visit Xsolla at Hall 2.2, Booth #A-030-B-037, where live demonstrations of Xsolla’s Payments, Web Shop, Mobile SDK and Backend will be held throughout the event. Xsolla’s team of experts will be available to answer questions, provide insights, and discuss how these tools can be tailored to meet the unique needs of each developer and publisher.
For more information, connect and book meetings with Xsolla at the Devcom Developer Conference and Gamescom 2024, visit xsolla.events/devcom24
About Xsolla
Xsolla is a global video game commerce company with a robust and powerful set of tools and services designed specifically for the industry. Since its founding in 2005, Xsolla has helped thousands of game developers and publishers of all sizes fund, market, launch, and monetize their games globally and across multiple platforms. As an innovative leader in game commerce, Xsolla’s mission is to solve the inherent complexities of global distribution, marketing, and monetization to help our partners reach more geographies, generate more revenue, and create relationships with gamers worldwide. Headquartered and incorporated in Los Angeles, California, with offices in Montreal, London, Berlin, Seoul, Beijing, Kuala Lumpur, Raleigh, Tokyo, and cities around the world, Xsolla supports major gaming titles like Valve, Twitch, Epic Games, Take-Two, KRAFTON, Nexters, NetEase, Playstudios, Playrix, miHoYo, and more.
For additional information and to learn more, please visit xsolla.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240818573649/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release
Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom